Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 46 out of 100. Digital health tools

Topic: Risk, prevention and care in population studies

Background The atherosclerotic cardiovascular disease (ASCVD) is associated with dementia. However, the risk factors of dementia in patients with ASCVD remain unclear, necessitating the development of accurate prediction models. Objective The aim of the study is to develop a machine learning model for use in patients with ASCVD to predict dementia risk using available clinical and sociodemographic data. Methods This prognostic study included patients with ASCVD between 2006 and 2010, with registration of follow-up data ending on April 2023 based on the UK Biobank. We implemented a data-driven strategy, identifying predictors from 316 variables and developing a machine learning model to predict the risk of incident dementia, Alzheimer disease, and vascular dementia within 5, 10, and longer-term follow-up in patients with ASCVD. Results A total of 29,561 patients with ASCVD were included, and 1334 (4.51%) developed dementia during a median follow-up time of 10.3 (IQR 7.6-12.4) years. The best prediction model (UK Biobank ASCVD risk prediction model) was light gradient boosting machine, comprising 10 predictors including age, time to complete pairs matching tasks, mean time to correctly identify matches, mean sphered cell volume, glucose levels, forced expiratory volume in 1 second z score, C-reactive protein, forced vital capacity, time engaging in activities, and age first had sexual intercourse. This model achieved the following performance metrics for all incident dementia: area under the receiver operating characteristic curve: mean 0.866 (SD 0.027), accuracy: mean 0.883 (SD 0.010), sensitivity: mean 0.637 (SD 0.084), specificity: mean 0.914 (SD 0.012), precision: mean 0.479 (SD 0.031), and F1-score: mean 0.546 (SD 0.043). Meanwhile, this model was well-calibrated (Kolmogorov-Smirnov test showed goodness-of-fit P value>.99) and maintained robust performance across different temporal cohorts. Besides, the model had a beneficial potential in clinical practice with a decision curve analysis. Conclusions The findings of this study suggest that predictive modeling could inform patients and clinicians about ASCVD at risk for dementia.

Key findings

Why it matters

In UK Biobank data from 29,561 patients with atherosclerotic cardiovascular disease, a machine learning model using clinical and sociodemographic variables predicted risk of incident dementia. The authors suggest this could inform patients and clinicians about risk, but it is a prediction tool, not a treatment, cure, or prevention.

Study details

How this study scored 46/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 4 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 2 of 7; Citations per year 1 of 5; Impact for its field and year 3 of 6; Cited by studies here 1 of 6; Still being cited 1 of 4; Senior author's track record 1 of 4; Institution's track record 1 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 46 of 100.46 of 100 points earned54 not earned

Published in a peer-reviewed journal. Scored zero for study design and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (JMIR Aging)
Journal's citation record 0 / 4 JMIR Aging: journal h-index 49 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 4 / 4 29,561 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 5 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.7 citations a year over 3 year(s) since 2025
Impact for its field and year 3 / 6 Cited 3.2× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 1 / 4 Cited 5 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Xingjie Shi: h-index 17 (OpenAlex, whole career)
Institution's track record 1 / 3 Fudan University: institution h-index 954 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40009844)
Free to read 2 / 2 Free to read
Total 46 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

APA 7th

Gu, Z. N., Liu, S., Ma, H., Long, Y., Jiao, X., Gao, X., et al. (2025). Estimation of Machine Learning–Based Models to Predict Dementia Risk in Patients With Atherosclerotic Cardiovascular Diseases: UK Biobank Study. JMIR Aging. https://doi.org/10.2196/64148

Vancouver

Gu ZN, Liu S, Ma H, Long Y, Jiao X, Gao X, et al. Estimation of Machine Learning–Based Models to Predict Dementia Risk in Patients With Atherosclerotic Cardiovascular Diseases: UK Biobank Study. JMIR Aging. 2025. doi:10.2196/64148. PMID: 40009844.

BibTeX

@article{gu2025-40009844,
  author  = {Gu, Z. N. and Liu, Shuang and Ma, Huijuan and Long, Yifan and Jiao, Xuehao and Gao, Xin and Du, Bingying and Bi, Xiaoying and others},
  title   = {{Estimation of Machine Learning–Based Models to Predict Dementia Risk in Patients With Atherosclerotic Cardiovascular Diseases: UK Biobank Study}},
  journal = {JMIR Aging},
  year    = {2025},
  doi     = {10.2196/64148},
  pmid    = {40009844},
  url     = {https://doi.org/10.2196/64148}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Digital health tools

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Similar studies

More on Digital health tools

See all studies in Digital health tools →